Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.97 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.85 |
| ▸ | HTR1A | P08908 | 2/20 | 0.64 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.61 |
| ▸ | LTA4H | P09960 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10669091 | 0.98 | HRH3 (1.00) | HRH3SIGMAR1HTR1ASLC6A4LTA4H | |
| Hydrochloric Acid SCHEMBL10352286 | 0.90 | HRH3 (0.78) | HRH3SIGMAR1SLC6A4 | |
| SCHEMBL22813625 | 0.89 | HRH3 (0.83) | HRH3SIGMAR1HTR1ASLC6A4LTA4H | |
| SCHEMBL2089103 | 0.86 | SIGMAR1 (0.82) | HRH3SIGMAR1HTR1ASLC6A4 | |
| SCHEMBL5709087 | 0.85 | HRH3 (0.71) | HRH3SIGMAR1SLC6A4LTA4H | |
| SCHEMBL11379089 | 0.85 | SIGMAR1 (0.80) | HRH3SIGMAR1HTR1ASLC6A4 | |
| SCHEMBL9387835 | 0.85 | SIGMAR1 (0.85) | HRH3SIGMAR1HTR1ASLC6A4 | |
| SCHEMBL29447356 | 0.84 | SIGMAR1 (0.77) | HRH3SIGMAR1 | |
| SCHEMBL1883482 | 0.84 | SIGMAR1 (0.77) | HRH3SIGMAR1 | |
| SCHEMBL17297948 | 0.84 | SIGMAR1 (0.78) | HRH3SIGMAR1HTR1ASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025104081-A1 | TRIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS | REMYND N.V. (BE) | 2025-05-22 | — | — | WO | disclosed |
| EP-3148537-A1 | CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTION | Université Paris Descartes (FR) | 2017-04-05 | — | — | EP | disclosed |
| WO-2015181387-A1 | CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTION | UNIVERSITE PARIS DESCARTES (FR) | 2015-12-03 | — | — | WO | disclosed |